ASAGI Labs Establishes Longevity Consortium

ASAGI Labs (Representative Director: Motoshi Hayano) has established the 'ASAGI Labs Longevity Consortium,' a platform where diverse stakeholders from industry, government, academia, and finance collaborate to promote R&D and new business co-creation related to longevity (extending healthy life expectancy and sustainable social participation) for all generations, and will begin full-scale activities on June 1, 2026. Against the backdrop of advances in aging research, the integration of multimodal information by AI, and the 'multi-staging of life,' this consortium aims to build a new social model that balances life planning based on individual narratives with the well-being of society as a whole. As a co-creation platform involving academia, companies, local governments, hospitals/clinics, and non-profit organizations, we will disseminate longevity solutions from Japan to the world. An era has arrived where it is possible to objectively calculate a person's true functional state and provide optimal interventions according to life stages by integrating and visualizing complex aging using integrated data and AI. On the other hand, increased longevity has made the 'education, work, retirement' life model a thing of the past, and individual 'narratives' are influencing not only medical care and healthcare but also choices in finance, insurance, careers, and housing. This consortium will plan the creation of new markets in the 'longevity clock' era across industries, such as drug discovery, medical devices, food and nutrition, wellness, health tourism, and health-linked finance, through member-led working groups, and implement concrete research and projects.